Behav Res Ther. 2006 May;44(5):657-65. Epub 2005 Jul 20.

One-year follow-up of pharmacotherapy-resistant patients with panic disorder treated with cognitive-behavior therapy: Outcome and predictors of remission.

Heldt E, Gus Manfro G, Kipper L, Blaya C, Isolan L, Otto MW.

Source

Anxiety Disorders Program, Hospital de Clínicas de Porto Alegre, RS and Post-Graduate Program in Medical Sciences: Psychiatry, Universidade Federal do Rio Grande do Sul, Brazil.

Abstract

Non-response to pharmacotherapy for panic disorder (PD) is a well-documented problem. However, little information exists to guide next-step strategies for these non-responders. In addition to pharmacologic augmentation strategies, several studies support the efficacy of cognitive-behavior therapy (CBT) for these patients, although data on long-term outcomes has been lacking. In this study, we provide one-year outcomes on a sample of 63 patients who completed group CBT for PD after failing to respond adequately to previous pharmacotherapy. Sustained significant benefit was found for all dimensional outcome scores, and nearly two-thirds of the sample met remission criteria. This occurred with reductions in medication use over the follow-up period. Negative predictors of remission status included comorbid dysthymia, social phobia, and generalized anxiety disorder. These results provide additional evidence for the efficacy of CBT for medication non-responders with PD.

PMID:: 16038874; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Clinical Trial

MeSH Terms

Substances

Anti-Anxiety Agents

LinkOut - more resources

Full Text Sources

Medical

Panic Disorder - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial. [J Clin Psychiatry. 2009]
Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial.
Simon NM, Otto MW, Worthington JJ, Hoge EA, Thompson EH, Lebeau RT, Moshier SJ, Zalta AK, Pollack MH. J Clin Psychiatry. 2009 Nov; 70(11):1563-70. Epub 2009 Oct 6.
Does concurrent drug intake affect the long-term outcome of group cognitive behaviour therapy in panic disorder with or without agoraphobia? [Behav Res Ther. 1997]
Does concurrent drug intake affect the long-term outcome of group cognitive behaviour therapy in panic disorder with or without agoraphobia?
Oei TP, Llamas M, Evans L. Behav Res Ther. 1997 Sep; 35(9):851-7.
Cognitive behavior therapy for treatment-refractory panic disorder. [J Clin Psychiatry. 1994]
Cognitive behavior therapy for treatment-refractory panic disorder.
Pollack MH, Otto MW, Kaspi SP, Hammerness PG, Rosenbaum JF. J Clin Psychiatry. 1994 May; 55(5):200-5.
Review Long-term outcome of cognitive behaviour therapy clinical trials in central Scotland. [Health Technol Assess. 2005]
Review Long-term outcome of cognitive behaviour therapy clinical trials in central Scotland.
Durham RC, Chambers JA, Power KG, Sharp DM, Macdonald RR, Major KA, Dow MG, Gumley AI. Health Technol Assess. 2005 Nov; 9(42):1-174.
Review Cognitive-behavior therapy and the longitudinal course of panic disorder. [Psychiatr Clin North Am. 1995]
Review Cognitive-behavior therapy and the longitudinal course of panic disorder.
Otto MW, Whittal ML. Psychiatr Clin North Am. 1995 Dec; 18(4):803-20.

See reviews... See all...

Cited by 7 PubMed Central articles

Review Pharmacotherapy of anxiety disorders: a critical review. [Dialogues Clin Neurosci. 2011]
Review Pharmacotherapy of anxiety disorders: a critical review.
Koen N, Stein DJ. Dialogues Clin Neurosci. 2011; 13(4):423-37.
Management of treatment-resistant panic disorder. [Psychiatry (Edgmont). 2007]
Management of treatment-resistant panic disorder.
Holt RL, Lydiard RB. Psychiatry (Edgmont). 2007 Oct; 4(10):48-59.
Predictors of clinical improvement in a randomized effectiveness trial for primary care patients with panic disorder. [J Nerv Ment Dis. 2009]
Predictors of clinical improvement in a randomized effectiveness trial for primary care patients with panic disorder.
Chavira DA, Stein MB, Golinelli D, Sherbourne CD, Craske MG, Sullivan G, Bystritsky A, Roy-Byrne PP. J Nerv Ment Dis. 2009 Oct; 197(10):715-21.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

One-year follow-up of pharmacotherapy-resistant patients with panic disorder tre...
One-year follow-up of pharmacotherapy-resistant patients with panic disorder treated with cognitive-behavior therapy: Outcome and predictors of remission.
Behav Res Ther. 2006 May ;44(5):657-65. Epub 2005 Jul 20 .

PubMed
Prevalence of personality disorders in patients with major depression and dysthy...
Prevalence of personality disorders in patients with major depression and dysthymia.
Psychiatry Res. 1992 Apr ;42(1):93-9.

PubMed
Scleroderma complicated with tamponade during pregnancy.
Scleroderma complicated with tamponade during pregnancy.
Joint Bone Spine. 2005 Jul ;72(4):341-3. Epub 2004 Dec 8 .

PubMed
Multicenter evaluation of the bovine mesenteric vein bioprostheses for hemodialy...
Multicenter evaluation of the bovine mesenteric vein bioprostheses for hemodialysis access in patients with an earlier failed prosthetic graft.
J Am Coll Surg. 2005 Aug ;201(2):223-30.

PubMed
Thrombin increases cardiomyocyte acute cell death after ischemia and reperfusion...
Thrombin increases cardiomyocyte acute cell death after ischemia and reperfusion.
J Mol Cell Cardiol. 2005 Aug ;39(2):277-83.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: